Navigation Links
ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
Date:2/12/2008

- Conference Call to Discuss Results to Be Held at 9:00 A.M. -

EXTON, Pa., Feb. 12 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (Nasdaq: VPHM) fourth quarter and year end financial results for 2007 and guidance for 2008 are expected to be released on Wednesday, February 27, 2008 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day. During the conference call, ViroPharma management will discuss the 2007 fourth quarter and full year financial results and other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com. An audio archive will be available at the same address until March 14, 2008. To participate in the conference call, please dial (877) 366-0713 (domestic) and (302) 607-2000 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ViroPharma to Present at the BIO CEO & Investor Conference
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at Two Upcoming Healthcare Conferences
4. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
5. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
6. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
7. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
10. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
11. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...FRANCISCO, Dec. 1 Medizo...announced today that in tests involving its propri...break "6 log" decontamination barriers, this time ...austridium difficile and Bacillis subtilis. These ...tremely potent sporicidal technology. "The implica...
(Date:12/1/2009)... DNA Genotek, a leading provider of produc...ed that Tepnel Pharmaceutical Services will offer ... its nucleic acid extraction and genotyping servic...ecember 1, 2009 -- DNA Genotek , a leading provid...oday announced that Tepnel Pharmaceutical Service...
(Date:12/1/2009)... iCardiac now provides services to three o..., Rochester, NY (PRWEB) De...lobal leader in advanced cardiac core lab services...pharmaceutical company has selected iCardiac as a ...ac will provide Highly Automated QT(sm) and Dynami...
(Date:11/30/2009)...MBUS, Ohio, Nov. 30 The Ohio Capit...he nation,s first minority business early-stage ca... December 3, is called "Transforming the Landscape...-Stage Capital Summit." It will feature several sp...ness leaders and local minority entrepreneurs. ,...
Breaking Biology Technology:Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2
...16 Epeius Biotechnologies,Corporation, a leader i...ed,two additional European patents for the platfor...t enable precision gene delivery to primary cancer...ut the body. With profound,demonstrations of clini...overall safety, Epeius Biotech continues to lead t...
...R) (zolpidem tartrate sublingual lozenge) as the f...ment of middle-of-the-night awakenings , , PT...cals, Inc., a privately-held specialty pharmaceuti...confirmation from the U.S. Food and Drug Administr...r Intermezzo (R) (zolpidem tartrate sublingual lo...
...6 Cardium Therapeutics (NYSE Alternext US: CXM) a...oday announced enrollment of the first patient in ...g conducted by researchers at the University of C...nnerCool,s new UroCool(TM), a pelvic catheter syst...otic-assisted prostatectomy surgery. , , (Log...
Other Biology Technology:Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate 2Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 2Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 3Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 4Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 5Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 2Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 3Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 4Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 5Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 6Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 7Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 8
(Date:12/1/2009)...e Yerkes National Primate Research Center, Emory U...ransgenic prairie voles, an important step toward ...e future application of this technology will enabl...tions that will help identify the brain mechanisms...ors. This advancement may also have important impl...
(Date:12/1/2009)...NYVALE, Calif., Dec. 1 GestureTek ...se 3.0 - a turnkey, portable, plug and play intera...xhibits, entertainment and touring promotions. Ges...tents in camera-enabled gesture recognition techno...ertainment systems. ,, Guaranteed for quality, ...
(Date:12/1/2009)...available in German . , Brown adipose tissue ...s of mitochondria, miniature power stations which... they normally generate a voltage similar to that ...lar processes. However, the mitochondria of brown ... ahead all the time. The energy released when the ...
Breaking Biology News(10 mins):Yerkes researchers create first transgenic prairie voles 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Brown fat cells make 'spare tires' shrink 2VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Mesa Labs Reports Higher First Quarter Earnings 54256 1Mesa Labs Reports Higher First Quarter Earnings 54256 2Mesa Labs Reports Higher First Quarter Earnings 54256 3Mesa Labs Reports Higher First Quarter Earnings 54256 4Mesa Labs Reports Higher First Quarter Earnings 54256 5Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
...ported this week in the online early edition of th..., finds that coal burning, primarily in North Ame...tially affected human health and ecosystems in and...d "Coal Burning Leaves Toxic Heavy Metal Legacy in... Institute (DRI), Reno, Nev. and partially funded ...
...orate product offerings and international distribu...outh Africa and neighboring ...RX Inc., (OTC,Bulletin Board: BMRX), today announc...idiary of Sequiam Corporation have been transferre... creditor, Biometric Investors LLC,(BIL). bioMETRX...
...-- The National Science Foundation,s Expeditions i... Molecular Programming Project, a collaborative ef... Technology and the University of Washington to es...mplex molecular and chemical systems based on the ...heir study, molecular programs, are collections of...
Other Biology News:Greenland ice core reveals history of pollution in the Arctic 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 3Caltech researchers awarded $10M for molecular programming project 2
SlideHyb Glass Array Hybridization Buffer #2 from Ambion
DNA Engine Opticon 2 Continuous Fluorescence Detection System from Bio-Rad
...n embedded tissue blocks, which are subjected to r...ighest quality. Tissues of each array are manually...of 7 microns and mounted on coated slides. Section...core sections made using Tissue Arrayer. Arrays en...
...signed and updated version of the original Tetrad ...en Alpha heat-pump assemblies. It delivers the sam...ne Dyad, and original Tetrad thermal cyclers, allo...The Tetrad 2 contains an onboard Pentium-class com...
Biology Products: